FRANKFURT (Reuters) -BioNTech said on Thursday that its collaboration with Pfizer has not changed, when asked to comment on a report that Pfizer is looking to sell its stake in the German biotech firm.
“We continue to have a close and strong collaboration,” a spokesperson said in a statement, adding that BioNTech would not be commenting on any capital market activities by Pfizer.
(Reporting by Ludwig Burger, editing by Thomas Escritt)
Brought to you by www.srnnews.com
